Targeted mutants show lysosomal storage in multiple tissues, increased urinary GAG, craniofacial and skeletal defects, increased body weight, impaired habituation and long-term memory for aversive training, reduced ventricular function with valve insufficiency, and progressive hearing loss.
|VEGA Gene Model||OTTMUSG00000027012 (Evidence)|
|Ensembl Gene Model||ENSMUSG00000033540 (Evidence)|
|Entrez Gene||15932 (Evidence)|
|DFCI||TC1581767, TC1641172, TC1707105|
|DoTS||DT.490894, DT.91438739, DT.94231558, DT.97392239|
|Consensus CDS Project||CCDS19516.2, CCDS71635.1|
|International Mouse Phenotyping Consortium Status||Idua|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update